Welcome!

News Feed Item

Bayer commends AHS and CAPC for updated heartworm guidelines

Important guideline revisions made by both parasite-focused organizations address heartworm prevention, treatment and diagnosis; and include information about FDA approval of the first-ever treatment for circulating microfilaria

SHAWNEE, Kan., Jan. 19, 2014 /PRNewswire/ -- Veterinarians wanting to keep their heartworm protocols up to date should check out the latest information from the American Heartworm Society (AHS) and the Companion Animal Parasite Council (CAPC), say representatives from the Bayer HealthCare LLC Animal Health division. New information on heartworm prevention, diagnosis and treatment recently prompted changes to the guidelines veterinarians rely on when establishing their heartworm protocols. Both AHS and CAPC have announced updates to their heartworm guidelines, citing—among other factors—new information about the documented presence of resistant sub-populations of heartworms.

"At Bayer, we commend these two organizations for their decision to revise their recommendations," said Cristiano von Simson, DVM, MBA, director of Veterinary Technical Services at Bayer HealthCare LLC Animal Health division, North America. The AHS guidelines reinforce the importance of year-round administration of heartworm preventives, support the administration of doxycycline and macrocyclic lactones prior to adulticide therapy and recommend both antigen and microfilaria testing. In addition, the AHS guidelines also referenced the recent U.S. Food and Drug Administration's (FDA) approval of Bayer's Advantage Multi® for Dogs (imidacloprid + moxidectin) as the first and only product labeled for circulating microfilaria treatment in heartworm positive dogs in the United States.

"Bayer is passionate about caring for animals and develops products and services that support veterinarians' ability to keep our pets healthy," said von Simson. "These updated guidelines, and the FDA's recognition of the importance of treating microfilaria, will strengthen veterinarians' capability to reduce the incidence and severity of heartworm disease in dogs."

According to the American Heartworm Society, there are conservatively 1 million cases of heartworm disease diagnosed in dogs every year.1 Heartworm disease most commonly results in abnormal functioning of the lungs, heart, liver and kidneys.2

New information on resistance, Wolbachia and diagnostic testing drive AHS updates
"AHS continually seeks the latest information when it comes to understanding and preventing heartworm disease," says Stephen Jones, DVM, President of the American Heartworm Society, noting that the latest update reflects information and research presented during the 2013 Triennial Heartworm Symposium. "Like the practitioners we serve, we need to be prepared to adjust our recommendations as new information becomes available. This past year was significant in terms of identifying new information about diagnosis, prevention and treatment of heartworm disease."

The American Heartworm Society's mission is to lead the veterinary profession, as well as further scientific progress in the study of heartworm disease, inform its members of new developments and help promote effective procedures for diagnosis, treatment and prevention of heartworm disease. The AHS' complete canine heartworm guidelines may be found at http://www.heartwormsociety.org/veterinary-resources/canine-guidelines.html.

The updated AHS feline guidelines can be found at: http://www.heartwormsociety.org/veterinary-resources/feline-guidelines.html.

Companion Animal Parasite Council revises heartworm guidelines for canines
Last month the Companion Animal Parasite Council published their latest revisions to the heartworm prevention and treatment guidelines which continue to advocate for year-round heartworm prevention for dogs and cats. This recommendation is based on parasite behaviors and human behaviors related to heartworm prevention. Like many other diseases, heartworm is much easier and less expensive to prevent than to treat. Consequently, pet owners should be educated about prevention and strongly encouraged to improve compliance by keeping up with year-round prevention.

"Given the very effective preventives available, dogs and cats shouldn't develop heartworm disease," says Susan E. Little, DVM, Ph.D., Professor of Parasitology at Oklahoma State University and President-elect of CAPC. "Nonetheless, a large number of pets continue to become infected each year due, in part, to the varying activity times and behaviors of the mosquitoes that transmit heartworm, making it impossible to target transmission seasons or locations precisely. Year-round prevention is of utmost importance."

The Companion Animal Parasite Council (CAPC) aims to foster animal and human health, while preserving the human-animal bond, through recommendations for the diagnosis, treatment, prevention and control of parasitic infections. CAPC's complete canine heartworm guidelines may be found here: http://www.capcvet.org/capc-recommendations/canine-heartworm/.

About Advantage Multi® for Dogs
For more information on Advantage Multi® for Dogs, visit http://www.bayerdvm.com/show.aspx/productdetail/advantage-multi-for-dogs
Product Label

CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. WARNING: DO NOT ADMINISTER THIS PRODUCT ORALLY. For the first 30 minutes after application ensure that dogs cannot lick the product from application sites on themselves or other treated animals. Children should not come in contact with the application sites for two (2) hours after application. (See Contraindications, Warnings, Human Warnings, and Adverse Reactions, for more information.) CONTRAINDICATIONS: Do not use this product on cats.

About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 18.6 billion (2012), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 54,900 employees (Dec. 31, 2012) and is represented in more than 100 countries. More information at www.healthcare.bayer.com.

Contact:

Staci Gouveia, Tel. 913.268.2577
Email: [email protected]

Lauren Dorsch, Tel. 913.268.2747
Email: [email protected]

Find more information about Bayer HealthCare Animal Health at
www.animalhealth.bayerhealthcare.com
Follow us on Twitter: @Bayer4animalsUS
Follow us on Facebook: http://www.facebook.com/healthcare.bayer  

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

1Weyenberg, K. (2009). Team Up Against Heartworm. The Team, pg. 10-12.
2American Heartworm Society, Pet Owner Glossary, http://www.heartwormsociety.org/pet-owner-resources/glossary.html. Accessed October 6, 2013.

SOURCE Bayer HealthCare Animal Health

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"We work around really protecting the confidentiality of information, and by doing so we've developed implementations of encryption through a patented process that is known as superencipherment," explained Richard Blech, CEO of Secure Channels Inc., in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
High-velocity engineering teams are applying not only continuous delivery processes, but also lessons in experimentation from established leaders like Amazon, Netflix, and Facebook. These companies have made experimentation a foundation for their release processes, allowing them to try out major feature releases and redesigns within smaller groups before making them broadly available. In his session at 21st Cloud Expo, Brian Lucas, Senior Staff Engineer at Optimizely, discussed how by using ne...
"Infoblox does DNS, DHCP and IP address management for not only enterprise networks but cloud networks as well. Customers are looking for a single platform that can extend not only in their private enterprise environment but private cloud, public cloud, tracking all the IP space and everything that is going on in that environment," explained Steve Salo, Principal Systems Engineer at Infoblox, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventio...
Agile has finally jumped the technology shark, expanding outside the software world. Enterprises are now increasingly adopting Agile practices across their organizations in order to successfully navigate the disruptive waters that threaten to drown them. In our quest for establishing change as a core competency in our organizations, this business-centric notion of Agile is an essential component of Agile Digital Transformation. In the years since the publication of the Agile Manifesto, the conn...
While some developers care passionately about how data centers and clouds are architected, for most, it is only the end result that matters. To the majority of companies, technology exists to solve a business problem, and only delivers value when it is solving that problem. 2017 brings the mainstream adoption of containers for production workloads. In his session at 21st Cloud Expo, Ben McCormack, VP of Operations at Evernote, discussed how data centers of the future will be managed, how the p...
"Cloud Academy is an enterprise training platform for the cloud, specifically public clouds. We offer guided learning experiences on AWS, Azure, Google Cloud and all the surrounding methodologies and technologies that you need to know and your teams need to know in order to leverage the full benefits of the cloud," explained Alex Brower, VP of Marketing at Cloud Academy, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clar...
"MobiDev is a software development company and we do complex, custom software development for everybody from entrepreneurs to large enterprises," explained Alan Winters, U.S. Head of Business Development at MobiDev, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that CrowdReviews.com has been named “Media Sponsor” of SYS-CON's 22nd International Cloud Expo, which will take place on June 5–7, 2018, at the Javits Center in New York City, NY. CrowdReviews.com is a transparent online platform for determining which products and services are the best based on the opinion of the crowd. The crowd consists of Internet users that have experienced products and services first-hand and have an interest in letting other potential buye...
In his session at 21st Cloud Expo, James Henry, Co-CEO/CTO of Calgary Scientific Inc., introduced you to the challenges, solutions and benefits of training AI systems to solve visual problems with an emphasis on improving AIs with continuous training in the field. He explored applications in several industries and discussed technologies that allow the deployment of advanced visualization solutions to the cloud.
"There's plenty of bandwidth out there but it's never in the right place. So what Cedexis does is uses data to work out the best pathways to get data from the origin to the person who wants to get it," explained Simon Jones, Evangelist and Head of Marketing at Cedexis, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"Space Monkey by Vivent Smart Home is a product that is a distributed cloud-based edge storage network. Vivent Smart Home, our parent company, is a smart home provider that places a lot of hard drives across homes in North America," explained JT Olds, Director of Engineering, and Brandon Crowfeather, Product Manager, at Vivint Smart Home, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"Codigm is based on the cloud and we are here to explore marketing opportunities in America. Our mission is to make an ecosystem of the SW environment that anyone can understand, learn, teach, and develop the SW on the cloud," explained Sung Tae Ryu, CEO of Codigm, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
The question before companies today is not whether to become intelligent, it’s a question of how and how fast. The key is to adopt and deploy an intelligent application strategy while simultaneously preparing to scale that intelligence. In her session at 21st Cloud Expo, Sangeeta Chakraborty, Chief Customer Officer at Ayasdi, provided a tactical framework to become a truly intelligent enterprise, including how to identify the right applications for AI, how to build a Center of Excellence to oper...
"IBM is really all in on blockchain. We take a look at sort of the history of blockchain ledger technologies. It started out with bitcoin, Ethereum, and IBM evaluated these particular blockchain technologies and found they were anonymous and permissionless and that many companies were looking for permissioned blockchain," stated René Bostic, Technical VP of the IBM Cloud Unit in North America, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventi...
"We're developing a software that is based on the cloud environment and we are providing those services to corporations and the general public," explained Seungmin Kim, CEO/CTO of SM Systems Inc., in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.